Returning to the pre-antibiotic era in the critically ill:... : Critical Care Medicine (original) (raw)
Editorials
Paterson, David L. MBBS, FRACP, FRCPA, PhD; Lipman, Jeffrey MBBCh, DA, FFA, FJFICM, MD
Royal Brisbane and Women’s Hospital, University of Queensland, Brisbane, Australia
Dr. Lipman has received grant funding from AstraZeneca. Dr. Paterson has received grant funding from Merck, Elan, Pfizer, and AstraZeneca and is a consultant to Acureon, Johnson and Johnson, and Merck.
© 2007 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins